AMAG Pharmaceuticals Inc (NASDAQ:AMAG)
| 18.50 Data as of Jul 24 |  0.00 / 0.00%Today’s Change | 16.49 Today|||52-Week Range 28.42 | -23.81% Year-to-Date |
Latest AMAG News | Press Releases
| Zacks Rank #5 Additions for Monday - Tale of the Tape Jul 21 / Zacks.com |
Today’s Trading
| Previous close | 18.50 |
| Today’s open | n.a. |
| Day’s range | 18.30 - 19.11 |
| Volume | 1,919 |
| Average volume (3 months) | 344,692 |
| Market cap | $417.3M |
| Dividend yield | -- |
Data as of 07/24/2014
Growth & Valuation
| Earnings growth (last year) | +43.59% |
| Earnings growth (this year) | -3.79% |
| Earnings growth (next 5 years) | +35.00% |
| Revenue growth (last year) | -5.30% |
| P/E ratio | NM |
| Price/Sales | 6.52 |
| Price/Book | 2.40 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| GERNGeron Corp | 0.00 | 0.00% |
| DNDNDendreon Corp | 0.00 | 0.00% |
| VCYTVeracyte Inc | +0.38 | +2.64% |
| GALTGalectin Therapeutic... | +0.24 | +1.78% |
Data as of 07/24/2014
Financials
| Next reporting date | July 30, 2014 |
| EPS forecast (this quarter) | -$0.09 |
| Annual revenue (last year) | $80.9M |
| Annual profit (last year) | -$9.6M |
| Net profit margin | -11.88% |
Profile
Sector Health Technology |
Industry Biotechnology |
President, Chief Executive Officer & Director William K. Heiden |
Chief Operating Officer & Executive Vice President Frank E. Thomas |
Corporate headquarters Lexington, Massachusetts |
Forecasts
.
